N-Acetyl Semax Amidate Guide
The Focus Nootropic
Deep dive into NA-Semax Amidate, the enhanced version of the Russian nootropic Semax. Unmatched BBB penetration for BDNF, focus, and dopamine modulation.
The Supercharged Nootropic Peptide
Semax is an ACTH analogue developed in Russia, widely used to prevent brain damage after strokes by massively upregulating BDNF (Brain-Derived Neurotrophic Factor). NA-Semax Amidate is an evolved, biohacked version of standard Semax.
By adding an Acetyl group to one end and an Amidate group to the other, the peptide becomes highly resistant to enzymatic breakdown in the blood and significantly better at crossing the Blood-Brain Barrier (BBB), resulting in a much more stimulating, focused effect at lower doses.
What is it?: Semax is an ACTH analogue developed in Russia, widely used to prevent brain damage after strokes by massively upregulating BDNF (Brain-Derived Neurotrophic Factor). NA-Semax Amidate is an evolved, biohacked version of standard Semax. By adding an Acetyl group to one end and an Amidate group to the other, the peptide becomes highly resistant to enzymatic breakdown in the blood and significantly better at crossing the Blood-Brain Barrier (BBB), resulting in a much more stimulating, focused effect at lower doses.
Mechanisms of Action
Clinical Dosing & Protocols
Vital Protocol FAQs
Guide FAQs
Deep dive into NA-Semax Amidate, the enhanced version of the Russian nootropic Semax. Unmatched BBB penetration for BDNF, focus, and dopamine modulation.
Yes. Shotlee supports tracking Na Semax Amidate doses, side effects, and health metrics. It is free to use.
Track Your Na Semax Amidate Protocol in Shotlee
Free dose logging, side effect tracking, and health metric monitoring for your complete protocol.
📚References & sources
Latest on Na Semax Amidate
RFK Jr.'s Peptide Policy Could Boost Hims & Hers GLP-1 Shift
Shares of Hims & Hers surged after HHS Secretary RFK Jr. revealed FDA plans to review peptides for compounding under the 503A bulk list. This comes as the telehealth leader evolves its high-margin compounded GLP-1 business toward branded options and new peptide therapies. CEO Andrew Dudum and CMO Dr. Patrick Carroll highlight the potential for regulated, physician-led peptide access.
6 min read
Semax: Potential of a Synthetic Peptide in Neuroscience Research
Semax, a synthetic heptapeptide derived from ACTH research, is capturing interest for its neuroactive properties without endocrine effects. Ongoing studies highlight its roles in neuroplasticity, stress resilience, and cognitive function. This guide delves into the science behind its multifaceted research potential.
5 min read
Semax Peptide: Research on Neuroprotection, Inflammation, and Vascular Effects
Semax, a synthetic heptapeptide, has demonstrated neuroregulatory, neuroprotective, and immunomodulating properties in various research models. This article examines its biochemical characteristics, possible effects on gene expression, interactions with neurotransmitter systems, vascular modulation, metal binding, and utility in ischemia-reperfusion injury studies.
5 min read